PTPhillip Te

Phillip Te

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Phillip Te has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Terminal Ileitis on Imaging Is Rarely Crohn's Disease: A 10‐Year Retrospective Cohort Study

    by Irene Lu, Carl Cosgrave, Phongsakone Inthavong, Phillip Te, Zacchary Tamsett, Jacoba van Wees, Neel Heerasing

    Background: Terminal ileitis is a common radiological finding in patients with abdominal pain and altered bowel habits. Although often associated with Crohn's disease (CD), it has a broad differential diagnosis including infectious, surgical, and malignant conditions. Prior studies suggest 20%–45% of terminal ileitis accounts for CD. This study aimed to evaluate the proportion of patients with computed tomography‐detected (CT) terminal ileitis diagnosed with CD and to assess clinical and biochemical predictors. Methods: A retrospective cohort study was conducted at a single tertiary hospital between 2014 and 2024. Adult patients with CT findings of terminal ileitis were included. Data were collected on demographics, laboratory values, stool testing, and endoscopic evaluation. Multivariable logistic regression was used to identify predictors of CD. Results: Of 128 patients, 16 (12.5%) were diagnosed with CD. Infectious (27.7%) and surgical (17.9%) etiologies were the most common causes of non‐CD terminal ileitis. Stool testing within 72 h was performed for 48.4% of patients, with 35.5% positive for pathogens. Endoscopic evaluation was performed in 59 patients (46%), and histopathological inflammation identified in 43.5% of biopsied cases. Lower albumin levels trended toward association with CD and were independently associated with CD on multivariable analysis (OR 0.82, 95% CI 0.72–0.94, p = 0.004). Conclusions: After evaluation, a small minority (12.5%) of patients with CT‐detected terminal ileitis were diagnosed with CD. Hypoalbuminemia was a significant predictor of CD, whereas routine inflammatory markers had limited diagnostic value. Larger prospective studies are needed to further refine the diagnostic algorithms for detection of CD in patients with terminal ileitis.

  • A challenging case of serum vasoactive intestinal peptide‐negative vasoactive intestinal peptide‐secreting tumour as cause of severe chronic diarrhoea

    by Phillip Te, Sahan Withanage, Carl Cosgrave, Damian Dowling, Mohammed Al‐Ansari

  • An Often-Forgotten Complication of Upadacitinib

    by Phillip Te, Richard Standish, Neel Heerasing

  • Open Access

    Kava Herb‐Induced Liver Injury as Verified by the Updated RUCAM

    by Sahan Withanage, Carl Cosgrave, Shoa Zafir, Eliza Flanagan, Phillip Te, Samuel Hall

    A temporal relationship between liver enzyme derangement and an herbal remedy warrants further assessment for herb‐induced liver injury (HILI). Here, we describe the use of kava, a drink traditionally consumed in Pacific Island cultures, causing acute ALT and AST elevation as assessed by an updated RUCAM score of 7. The increasing use of kava in Western society should prompt clinicians to be more aware of this rare cause of HILI. A 46‐year‐old man was referred to the emergency department with a 3‐week history of fatigue, right upper quadrant pain, and profound transaminitis. He commenced kava 10 g daily 5 weeks prior to aid sleep, which was ceased 2 weeks prior due to his biochemical derangement. Blood tests revealed an ALT of 1546 U/L and an AST of 920 U/L. An autoimmune screen, viral serology, and liver ultrasound showed no abnormalities. A liver biopsy revealed foci of hepatocellular necrosis with scattered ballooning degeneration and apoptotic bodies in the parenchyma, but normal underlying hepatic parenchyma without steatosis. Following cessation of kava, the liver enzymes improved without any other intervention. He was monitored as an outpatient and had no recurrence. The incidence of kava HILI may increase with its marketing; its exact mechanism is unknown. Ultimately, further research is needed to identify the pathogenesis of kava HILI. HILI is a significant cause of transaminitis, and clinicians should remain vigilant in patients presenting with nonspecific symptoms and a negative liver screen.